Chrys Capital weighs bid for Medley Pharma

Premium

Private Equity major Chrys Capital, and its limited partners, have entered the fray to acquire Medley Pharmaceuticals, three people aware of the development said. Strategic bidders, such as Cipla and Torrent Pharma, are also in the race to buy the business.  Chrys Capital may receive the backing of limited partner Ontario ......